InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,857.60
(
0.00%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
73.93
(
2.13%
)
Bitcoin
62,160.29
(
0.79%
)
Post# of 16729
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Money $hot

Send PM Follow Ignore
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Money $hot

Re: None

Monday, 11/19/2018 8:47:44 AM

Monday, November 19, 2018 8:47:44 AM

Post# of 16729
A Phase II Clinical Trial Shotgun Start @ Nash Pharmaceuticals



/////AMG


Red Pills

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM

One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM

Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM

Start posting your company's news
Only $200 per official company press release!